• Seeking a unique treatment for lobular breast cancer

    1 month ago - By ScienceDaily

    In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer - which affects some 40,000 women a year - researchers began looking at the role of the protein MDC1 in tumor cells.
    Read more ...


  • How Many Years of Aromatase Inhibitor Tx in Breast Cancer?

    1 month ago - By Medscape

    There was no disease-free or overall survival benefit with 5 additional years of aromatase inhibitor therapy vs 2 years for women with hormone receptor-positive breast cancers.
    Medscape Medical News
    Read more ...